In our study, the 10 new K-Ras-mutated cases presented clinical/biological characteristics usually associated with K-Ras mutations in NSCLC (Ahrendt et al, 2001; Broermann et al, 2002; Sugio et al, 2006; Tam et al, 2006). Here, KRAS is linked to non-small cell lung carcinoma.